BIO-TECHNE Corp Estimated Litigation Liability
BIO-TECHNE Corp (TECH) had Estimated Litigation Liability of $0 as of 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LitigationReserve · last filed 2026-08-24
- 2026-06-30: Estimated Litigation Liability $0.00.
- 2025-06-30: Estimated Litigation Liability $0.00.
- 2025-03-31: Estimated Litigation Liability $0.00.
- 2024-12-31: Estimated Litigation Liability $0.00.
| Period end | Estimated Litigation Liability |
|---|---|
| 2026-06-30 | $0.00 10-K · filed 2026-08-24 |
| 2025-06-30 | $0.00 10-K · filed 2026-08-24 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-06 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-05 |
| 2024-06-30 | $0.00 10-K · filed 2026-08-24 |
| 2023-06-30 | $0.00 10-K · filed 2025-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |